Project Grant R15CA294297
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$478K
Federal Agency
National Cancer Institute
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
Denton, TX 76204, USA
Similar Awards
This $753,446 Project Grant award from the National Cancer Institute's Cancer Cause and Prevention Research program (CFDA 93.393) aims to adapt and test an intervention to improve cervical cancer screening and follow-up in three diverse, underserved populations: urban inner city Blacks/Haitians in Boston, Hispanic immigrants in Florida, and Hawaiian Natives/Pacific Islanders in Hawaii. The intervention combines education and quality improvement methods using a mechanism called Performance...
This federal Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), supports a $644,804 research project titled "Advancing Breast Cancer Risk Assessment for Black Women." The project aims to develop and validate a novel deep learning-based breast cancer risk assessment tool focused on Black women, leveraging digital breast tomosynthesis (DBT) imaging data. Key objectives include: Developing a DBT-driven...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Research Manpower (CFDA 93.398) program, aims to optimize a bundled breast and cervical cancer screening program in Cameroon. The $192,780 award to the University of Alabama at Birmingham (UAB) supports implementation science research to 1) evaluate the reach and effectiveness of the screening program across stationary and mobile clinics, 2) identify implementation outcomes of acceptability, appropriateness,...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $547,047 to Georgetown University to test the bundling of multicancer screening, genetic services navigation, and other interventions to improve cancer screening rates and reduce health disparities among non-Hispanic Black and Hispanic women. The project aims to address patient- and organization-level barriers that limit access to cancer screening and genetic testing,...
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...
This federal Project Grant award, valued at $801,832, was provided by the National Institute on Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research program (CFDA 93.307). The award aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a multi-level integrated intervention that combines lung cancer screening using low-dose computed tomography (LDCT) and smoking cessation efforts. The key goals...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $714,062 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the biological mechanisms contributing to racial disparities in head and neck cancer outcomes, particularly among Black patients. The key objectives are to: 1) Develop a prognostic model using gene expression signatures to predict disease progression in early-stage oral squamous cell...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $176,534 to Oregon Health & Science University (OHSU) from August 1, 2024 to July 31, 2029. The goals of the research are to: (1) describe cervical cancer screening rates among middle to older age Mexican immigrants at a 23-state network of community health centers (CHCs) from 2012-2023; (2) examine individual, organizational, and structural barriers to cervical cancer...
This $189,540 Project Grant award, funded by the National Cancer Institute's Cancer Research Manpower (CFDA 93.398) program, supports a study to elucidate racial and ethnic differences in the functional effects of the vaginal microbiome on ovarian cancer. The study, conducted by Duke University, will apply an untargeted metabolomics approach to compare metabolite profiles of cervicovaginal fluid samples from 120 ovarian cancer patients across Black, Hispanic, and White racial/ethnic groups....
The National Cancer Institute (NCI) awarded a Project Grant under the federal Cancer Cause and Prevention Research program (CFDA 93.393) to The University of South Dakota (USD) to develop and test the efficacy and feasibility of a mobile web app intervention (WPAP) to promote cervical cancer screening among indigenous women. The $300,374 award will fund a 4-year project period from September 1, 2024 to August 31, 2028. The project aims to increase cervical cancer screening rates among indigenous...